Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Strittmatter

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
FEBS Letters|December 9, 1996
Toxicity of expanded polyglutamine-domain proteins in Escherichia coliO Onodera, A D Roses, S Tsuji, et al.
Biochemical and Biophysical Research Communications|February 28, 1994
Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein EJ S Whitson, M P Mims, W J Strittmatter, et al.
Brain Research Bulletin|September 1, 1988
Glutamate and dynorphin release from a subcellular fraction enriched in hippocampal mossy fiber synaptosomesD M Terrian, D Johnston, B J Claiborne, et al.
Neuroscience Letters|June 16, 1995
ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylationD Y Huang, K H Weisgraber, M Goedert, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cellsO Onodera, J R Burke, S E Miller, et al.
Journal of Neurochemistry|March 7, 1998
Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluidJ R Guyton, S E Miller, M E Martin, et al.
Lancet (London, England)|January 7, 1995
Apolipoprotein E in Creutzfeldt-Jacob diseaseA D Roses, A M Saunders, W J Strittmatter, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer diseaseW J Strittmatter, A M Saunders, D Schmechel, et al.
Journal of Neurochemistry|February 26, 1999
Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerabilityA J Cooper, K F Sheu, J R Burke, et al.
Lancet (London, England)|June 18, 1994
Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseA D Roses, W J Strittmatter, M A Pericak-Vance, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
FEBS Letters|December 9, 1996
Toxicity of expanded polyglutamine-domain proteins in Escherichia coliO Onodera, A D Roses, S Tsuji, et al.
Biochemical and Biophysical Research Communications|February 28, 1994
Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein EJ S Whitson, M P Mims, W J Strittmatter, et al.
Brain Research Bulletin|September 1, 1988
Glutamate and dynorphin release from a subcellular fraction enriched in hippocampal mossy fiber synaptosomesD M Terrian, D Johnston, B J Claiborne, et al.
Neuroscience Letters|June 16, 1995
ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylationD Y Huang, K H Weisgraber, M Goedert, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cellsO Onodera, J R Burke, S E Miller, et al.
Journal of Neurochemistry|March 7, 1998
Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluidJ R Guyton, S E Miller, M E Martin, et al.
Lancet (London, England)|January 7, 1995
Apolipoprotein E in Creutzfeldt-Jacob diseaseA D Roses, A M Saunders, W J Strittmatter, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer diseaseW J Strittmatter, A M Saunders, D Schmechel, et al.
Journal of Neurochemistry|February 26, 1999
Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerabilityA J Cooper, K F Sheu, J R Burke, et al.
Lancet (London, England)|June 18, 1994
Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseA D Roses, W J Strittmatter, M A Pericak-Vance, et al.
Pageof 9